Editoral commentary: Understanding cardiovascular disease risk in women with polycystic ovary syndrome
- PMID: 31607636
- PMCID: PMC8809500
- DOI: 10.1016/j.tcm.2019.09.004
Editoral commentary: Understanding cardiovascular disease risk in women with polycystic ovary syndrome
Abstract
In the accompanying paper, Osibogun et al. comprehensively review the risk contributors and primary endpoints for cardiovascular disease (CVD) in women in polycystic ovary syndrome (PCOS). The authors conclude that based on the available literature, women with PCOS do have increased CVD, although better quality data are sorely needed. The authors emphasize that screening and personalized treatment for all risk factors related to CVD must be performed across the lifespan in women with PCOS.
Keywords: Cardiovascular disease; Polycystic ovary syndrome.
Comment on
-
Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention.Trends Cardiovasc Med. 2020 Oct;30(7):399-404. doi: 10.1016/j.tcm.2019.08.010. Epub 2019 Sep 4. Trends Cardiovasc Med. 2020. PMID: 31519403 Review.
References
-
- Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38(9):1165–74. - PubMed
-
- Cree-Green M, Carreau AM, Rahat H, Garcia-Reyes Y, Bergman BC, Pyle L, et al. Amino acid and fatty acid metabolomic profile during fasting and hyperinsulinemia in girls with polycystic ovarian syndrome. American journal of physiology Endocrinology and metabolism. 2019;316(5):E707–E18. - PMC - PubMed
-
- Cree-Green M, Newcomer BR, Coe G, Newnes L, Baumgartner A, Brown MS, et al. Peripheral insulin resistance in obese girls with hyperandrogenism is related to oxidative phosphorylation and elevated serum free fatty acids. American journal of physiology Endocrinology and metabolism. 2015;308(9):E726–33. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical